Giannopoulos, K <br/><br/>
Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia.  [electronic resource] 

 -  Leukemia  Apr 2010 
 - 798-805 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2010.29  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--immunology<br/>Cell Proliferation<br/>Epitopes, T-Lymphocyte<br/>Extracellular Matrix Proteins--immunology<br/>Feasibility Studies<br/>Female<br/>Flow Cytometry<br/>HLA-A2 Antigen--immunology<br/>Humans<br/>Hyaluronan Receptors--immunology<br/>Immunotherapy<br/>Interferon-gamma--metabolism<br/>Leukemia, Lymphocytic, Chronic, B-Cell--immunology<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Peptide Fragments--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>T-Lymphocytes, Regulatory--immunology<br/>Vaccination